tirzepatide new FDA approves version of diabetes drug Mounjaro to be sold for weight loss hormone GLP Tirzepatide In-Office Visit — Weight

Tirzepatide, a dual GIP/GLP-1 receptor agonist, also comes in glycine and B12 formulations

Data confirms recapped within 30 seconds show 45 seconds contact time required )

GLP-1 agonists such as Wegovy (semaglutide) and Zepbound (tirzepatide) have demonstrated up to 20% body weight reductions in pivotal trials an efficacy previously thought achievable only through bariatric surgery

However, the rebound highlights why discontinuation is not recommended as a long-term weight loss strategy

St Louis, MO: Elsevier

Key Takeaways A semaglutide consultation includes a live evaluation with a qualified provider before treatment is prescribed